NDAORALTABLET, EXTENDED RELEASE
Approved
Jul 2014
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TARGINIQ is an extended-release oral tablet combining oxycodone (an opioid analgesic) with naloxone (an opioid antagonist) approved in 2014 for pain management. The naloxone component is designed to deter abuse by precipitating withdrawal if the tablet is crushed or injected, while oxycodone provides sustained pain relief. This abuse-deterrent formulation addresses regulatory and public health concerns around prescription opioid misuse.
Peak
Product is at peak lifecycle stage; brand teams are focused on market maintenance and managing competitive pressure rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TARGINIQ offers exposure to the high-scrutiny opioid market where regulatory acumen, prescriber relationship management, and risk/compliance discipline are essential. Career growth is constrained by the peak lifecycle stage and limited clinical pipeline, making this a solid operational role rather than a high-growth opportunity.
Brand ManagerMedical Science Liaison
Worked on TARGINIQ at Purdue Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.